Latest period
$14.66B
YoY change
-21.1%
5Y CAGR
-8.5%
Peak year (2020)
$22.95B
Latest annual
$14.71B
Total Equity history chart for Viatris (VTRS) from 2003 to 2025
Latest: $14.71B
Total Equity growth chart for Viatris (VTRS) from 2003 to 2025
Latest: -21.1%
Total Equity history table for Viatris (VTRS) from 2003 to 2025
| 2025 | $14.71B | -21.1% | −$3.92B | ||
| 2024 | $18.64B | -9.0% | −$1.83B | ||
| 2023 | $20.47B | -2.9% | −$604.90M | ||
| 2022 | $21.07B | +2.8% | +$579.60M | ||
| 2021 | $20.49B | -10.7% | −$2.46B | ||
| 2020 | $22.95B | +93.2% | +$11.07B | ||
| 2019 | $11.88B | -2.3% | −$283.30M | ||
| 2018 | $12.17B | -8.6% | −$1.14B | ||
| 2017 | $13.31B | +19.7% | +$2.19B | ||
| 2016 | $11.12B | +13.8% | +$1.35B | ||
| 2015 | $9.76B | +199.9% | +$6.51B | ||
| 2014 | $3.26B | +10.7% | +$314.10M | ||
| 2013 | $2.94B | -11.9% | −$398.92M | ||
| 2012 | $3.34B | -4.3% | −$151.06M | ||
| 2011 | $3.49B | -3.1% | −$110.10M | ||
| 2010 | $3.60B | +15.0% | +$470.73M | ||
| 2009 | $3.13B | +13.5% | +$373.41M | ||
| 2008 | $2.76B | -19.0% | −$645.69M | ||
| 2007 | $3.40B | — | — | ||
| 2005 | $787.65M | -57.3% | −$1.06B | ||
| 2004 | $1.85B | +11.2% | +$186.15M | ||
| 2003 | $1.66B | — | — |
- 2025$14.71B-21.1%
- 2024$18.64B-9.0%
- 2023$20.47B-2.9%
- 2022$21.07B+2.8%
- 2021$20.49B-10.7%
- 2020$22.95B+93.2%
- 2019$11.88B-2.3%
- 2018$12.17B-8.6%
- 2017$13.31B+19.7%
- 2016$11.12B+13.8%
- 2015$9.76B+199.9%
- 2014$3.26B+10.7%
- 2013$2.94B-11.9%
- 2012$3.34B-4.3%
- 2011$3.49B-3.1%
- 2010$3.60B+15.0%
- 2009$3.13B+13.5%
- 2008$2.76B-19.0%
- 2007$3.40B—
- 2005$787.65M-57.3%
- 2004$1.85B+11.2%
- 2003$1.66B—
Total Equity values are taken from Viatris's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Viatris (VTRS)
According to Viatris's latest reported financial statements, the company's latest reported total equity is $14.66B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Viatris (VTRS) most recent annual total equity stands at $14.71B (2025) – declined 21.1% year-over-year.
Viatris total equity has contracted on net over the period, with a -8.5% compound annual growth rate over 2020–2025 (5 years).
Viatris total equity plunged from $22.95B in 2020 to $14.71B in 2025, a 35.9% drawdown.
Across the available history, total equity reached its high of $22.95B in 2020 and its low of $787.65M in 2005.
Viatris Total Equity by Year
Viatris Total Equity 2025: $14.71B
In 2025, Viatris reported total equity of $14.71B, declined 21.1% below 2024.
Viatris Total Equity 2024: $18.64B
Viatris total equity in 2024 was $18.64B, declined 9.0% below 2023.
Viatris Total Equity 2023: $20.47B
2023's total equity for Viatris came in at $20.47B, edged down 2.9% below 2022.
Viatris Total Equity 2022: $21.07B
Viatris posted total equity of $21.07B in 2022, edged up 2.8% from 2021.
Viatris Total Equity 2021: $20.49B
Viatris total equity in 2021 was $20.49B.
See more financial history for Viatris (VTRS).
Sector peers by Total Equity
Healthcare peers of Viatris (VTRS), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation